Two Sigma Advisers’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-282,000
| Closed | -$9.86M | – | 2758 |
|
|
2024
Q1 | $9.86M | Buy |
282,000
+71,200
| +34% | +$2.49M | 0.02% | 544 |
|
|
2023
Q4 | $8.01M | Sell |
210,800
-99,400
| -32% | -$3.78M | 0.02% | 621 |
|
|
2023
Q3 | $5.69M | Buy |
310,200
+17,200
| +6% | +$316K | 0.01% | 673 |
|
|
2023
Q2 | $7.61M | Buy |
293,000
+19,100
| +7% | +$496K | 0.02% | 591 |
|
|
2023
Q1 | $5.17M | Buy |
273,900
+67,100
| +32% | +$1.27M | 0.01% | 793 |
|
|
2022
Q4 | $5.1M | Buy |
206,800
+57,000
| +38% | +$1.4M | 0.01% | 775 |
|
|
2022
Q3 | $2.69M | Buy |
149,800
+105,600
| +239% | +$1.9M | 0.01% | 1025 |
|
|
2022
Q2 | $502K | Buy |
44,200
+27,600
| +166% | +$313K | ﹤0.01% | 1922 |
|
|
2022
Q1 | $370K | Buy |
+16,600
| New | +$370K | ﹤0.01% | 2137 |
|
|
2021
Q2 | – | Sell |
-10,500
| Closed | -$211K | – | 2848 |
|
|
2021
Q1 | $211K | Buy |
+10,500
| New | +$211K | ﹤0.01% | 2347 |
|